Management of Vicharchika by Pothos scandens.

A pharmacoclinical evaluation of Minapatrika (Pothos scandens Linn.)- An extra-pharacopoeial drug.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018371

Enrollment

Registered

2019-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

Intervention1: 3 gm of Pothos scandens leaf powder twice a day: Route- Oral Duration- 28 days Control Intervention1: Not applicable as this is single arm trial: Not applicable as this is single arm tr

Eligibility

Inclusion criteria

Inclusion criteria: 1.Classical signs and symptoms of Vicharchika like Kandu, Pidika, Vaivarnyata, Daha, Rukshata, Vedana etc. 2.Uncomplicated cases of Vicharchika 3.Age group: 18 - 60 yrs. 4.Acute cases of

Exclusion criteria

Exclusion criteria: 1.Age more than 60 years and below 18 years. 2.Suffering with systemic diseases like Diabetes, Hypertension, Malignancy, Tuberculosis, Renal diseases, Liver diseases etc. 3.Chronic cases of > 1 year history. 4.Lesions of larger surface area.

Design outcomes

Primary

Measure	Time frame
Relief in Itching, burning, roughness, pain etc symptoms of VicharchikaTimepoint: 28 days	—

Secondary

Measure	Time frame
Improvement in signs and symptoms of VicharchikaTimepoint: 28 days.	—

Countries

India

Contacts

Public ContactProf Rabinarayan Acharya

Institute of post graduate teaching and research in ayurveda Jamnagar

drrnacharya@gmail.com9924585855

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026